Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 23, 2025
'Psychodynamic Chaplaincy: Psychological and Spiritual Integration in Healthcare' Marks SCA's 10th Foundational Paper
EIN Presswire
·
April 23, 2025
NEW YORK, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Spiritual Care Association (SCA) is thrilled to announce the publication of its latest foundational paper, "Psychodynamic Chaplaincy: Psychological and Spiritual Integration in Healthcare …
RR Legacy Cannabis Recognized Under the New York State’s Licensing Program
EIN Presswire
·
April 23, 2025
RR Legacy Cannabis …
Revitalize Dermatology & Aesthetics Celebrates Spring with Exciting Happy Hour Event on May 9, 2025
EIN Presswire
·
April 23, 2025
FAYETTEVILLE, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Revitalize Dermatology …
Summit Appliance Unveils New Collection of Commercial Ice Machines Featuring High-Volume Production
EIN Presswire
·
April 23, 2025
Felix Storch, Inc. Expands Its Selection of Commercially Approved Clear Ice Machines With New ENERGY STAR Certified Series BRONX, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- A trusted supplier in the manufacturing industry since 1969, Summit …
'Students Are Heroes: A Sickle Cell Warriors Story' Trailer Screening at Annual Sickle Cell Consortium Leadership Summit
EIN Presswire
·
April 23, 2025
NEW YORK, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Music Brings Life, the dynamic non-profit organization dedicated to raising awareness about the importance of blood donations in underrepresented communities, is proud to announce the …
World Parkinson Coalition® Launches Care Partner Virtual Webinar
EIN Presswire
·
April 23, 2025
WPC honors Parkinson’s Awareness Month with New 3-panel webinar NEW YORK, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- In honor of Parkinson’s Awareness Month, the World Parkinson Coalition (WPC) is holding its WPC Care Partner Virtual …
Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin
GlobeNewswire
·
April 23, 2025
ROCKVILLE, Md. and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
Sen-Jam Showcases Longevity Insights at Global Health Summit in West Palm Beach
EIN Presswire
·
April 23, 2025
Sen-Jam’s Chief Clinical Officer unveils mast cell-driven anti-inflammatory science at elite West Palm Beach summit focused on longevity and wellness. HUNTINGTON, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Sen-Jam Pharmaceutical Takes the …
Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)
GlobeNewswire
·
April 23, 2025
– Significant blood pressure reductions among patients with uncontrolled or resistant hypertension treated with lorundrostat reinforce key role of dysregulated aldosterone in disease onset and progression – – Detailed results from the second pivotal Phase …
Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
GlobeNewswire
·
April 23, 2025
ROCKVILLE, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced …
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
GlobeNewswire
·
April 23, 2025
CARLSBAD, California, April 23, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it …
Jushi Holdings Inc. to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 23, 2025
BOCA RATON, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …
Aptose Announces Auditor Not Standing for Re-Appointment
GlobeNewswire
·
April 23, 2025
SAN DIEGO and TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with …
Amedisys Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 23, 2025
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March 31, 2025 and 2024 Net service revenue increased $23.4 …
Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced plans to …
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
GlobeNewswire
·
April 23, 2025
BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A …